Article ; Online: Generation of myoglobin (MB)-knockout human embryonic stem cell (hESC) line (KAIMRCe002-A-1S) using CRISPR/Cas9 technology.
2023 Volume 71, Page(s) 103158
Abstract: Myoglobin (MB) is a cytoplasmic hemoprotein that is predominantly expressed in the heart and oxidative myofibers of skeletal muscle. It has been demonstrated that MB binds to oxygen and promotes its diffusion for energy production in the mitochondria. ... ...
Abstract | Myoglobin (MB) is a cytoplasmic hemoprotein that is predominantly expressed in the heart and oxidative myofibers of skeletal muscle. It has been demonstrated that MB binds to oxygen and promotes its diffusion for energy production in the mitochondria. Recently, MB was found to be expressed in different forms of malignant tumors and cancer cell lines. Further studies using gene disruption technology will enhance the understanding of MB's role in human cardiovascular biology and cancers. Here, we describe the generation of a homozygous MB knockout in human embryonic stem cells (hESC-MB |
---|---|
MeSH term(s) | Humans ; Myoglobin/genetics ; Myoglobin/metabolism ; Human Embryonic Stem Cells/metabolism ; CRISPR-Cas Systems/genetics ; Cell Line ; Technology |
Chemical Substances | Myoglobin |
Language | English |
Publishing date | 2023-06-25 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2393143-7 |
ISSN | 1876-7753 ; 1873-5061 |
ISSN (online) | 1876-7753 |
ISSN | 1873-5061 |
DOI | 10.1016/j.scr.2023.103158 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.